Search
for
Sort by
Research 30 of 137
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- BH16 Central centrifugal cicatricial alopecia and fibroproliferative disorders: exploring the association with uterine leiomyomas
- Risk factors and comorbidities associated with central centrifugal cicatricial alopecia
- Androgenic alopecia in postmenopausal ovarian hyperthecosis
- MON-LB044 Bilateral Ovarian Hyperthecosis: A Benign and Unusual Cause of Postmenopausal Hirsutism
- Iron Deficiency Anemia Diagnosed in the Private Practice Setting,
- An Exclusive Review on Menstrual Problems
- Women’s health-what’s new worldwide
- Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
- Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- Postmenopausal virilization after spousal use of topical androgens
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy
- Effective medical treatment for common baldness in women
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Testosterone therapy in women: Myths and misconceptions
- Alternative uses of dermoscopy in daily clinical practice: An update
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Gender-Affirming Hormone Therapy for Transgender Females
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Women's midlife health Reframing menopause
- Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study
- Venous thromboembolism and women's health
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Testosterone implants in women: Pharmacological dosing for a physiologic effect
- Ashy Dermatosis
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels